Share
Tradeoffs
Tradeoffs in 2024
We've got a lot to share with you in 2024!
We're looking into how fentanyl and other synthetic opioids are upending long established treatments for opioid addiction, and what clinicians and policymakers are doing to adapt.
There are a bunch of cases in the courts this year that have the potential to change Americans' access to care, and restrict the power of federal health agencies.
And nearly 25 years after a landmark case, declaring that people with intellectual and developmental disabilities have a right to live outside state-run institutions, we examine how doctors, hospitals and insurers are failing many of them … and one woman's work to forge a better path.
New episodes start 25 January, 2024!
Sign up for our weekly newsletter.
Support this type of journalism today, with a gift.
More episodes
View all episodes
300. Trump Forced Hospitals and Insurers to Reveal Their Prices. What Happened?
14:24||Season 1, Ep. 300A mandate to make health care prices public was one of President Trump’s signature health policies in his first term. But forcing hospitals to publish prices hasn’t yet helped patients shop around for medical care.Guest:Melanie Evans, Producer, TradeoffsLearn more and read a full transcript on our website.Want more Tradeoffs? Sign up for our free weekly newsletter featuring the latest health policy research and news.Support this type of journalism today, with a gift.299. Everyone’s Mad at Health Insurers, But 'There’s Plenty of Blame to Go Around'
22:08||Season 1, Ep. 299The murder of UnitedHealthcare's CEO put a violent point on the frustration and rage some Americans feel toward health insurance companies. But insurers are just one piece of America’s broken and expensive health care system.Guest:Aaron Carroll, CEO, Academy HealthLearn more and read a full transcript on our website.Want more Tradeoffs? Sign up for our free weekly newsletter featuring the latest health policy research and news.Support this type of journalism today, with a gift.298. Presenting: First Opinion: Mark Cuban
34:00||Season 1, Ep. 298Businessman and entertainer Mark Cuban has long had an interest in health care, and a mission to disrupt the pharmaceutical industry.Torie Bosch, host of First Opinion, a podcast from STAT News, speaks with Cuban about one of his latest ventures Cost Plus Drugs - Mark’s efforts to drive down prescription drug prices. Guests:Torie Bosch, Editor, First Opinion, STAT NewsMatt Herper, Senior Writer, Medicine, STAT NewsMark Cuban, Co-Founder Cost Plus Drugs EntrepreneurLearn more and read a full transcript on here.Want more Tradeoffs? Sign up for our free weekly newsletter featuring the latest health policy research and news.Support this type of journalism today, with a gift.297. Can the U.S. Put an End to Surprise Ambulance Bills?
32:40||Season 1, Ep. 297Congress banned most surprise medical bills back in 2020, with one major exception: ambulance rides. Most people agree that patients should be shielded from these unexpected charges. But who should pick up the tab instead? As state and federal policymakers grapple with that question, we delve into why finding a fair solution is harder than you’d think.Guests:Tara Bannow, Reporter, STATPrecious Mae Clark, patientDia Gainor, Executive Director, National Association of State EMS OfficialsZach Gaumer, Principal, Health Management AssociatesJames Gelfand, JD President and CEO, ERISA Industry CommitteeBob Herman, Reporter, STATPete Lawrence, Deputy Chief, Oceanside FireButch Oberhoff, President, Texas EMS AllianceLeslie Walker, Senior Reporter/Producer, TradeoffsMatt Zavadsky, At-Large Director, National Association of EMTsLearn more and read a full transcript on our website.Want more Tradeoffs? Sign up for our free weekly newsletter featuring the latest health policy research and news.Support this type of journalism today, with a gift.296. What Could RFK Jr. Do As Head of HHS? We Asked Someone Who’s Done the Job
23:17||Season 1, Ep. 296Former HHS Secretary Kathleen Sebelius shares what the country’s top health official can and can’t do, and what she wants senators to consider ahead of RFK’s confirmation hearings.Guest:Kathleen Sebelius, Former U.S. Secretary of Health and Human Services SecretaryLearn more and read a full transcript on our website.Want more Tradeoffs? Sign up for our free weekly newsletter featuring the latest health policy research and news.Support this type of journalism today, with a gift.295. Health Care for Transgender Youth Goes to the Supreme Court
26:11||Season 1, Ep. 295Twenty-six states have passed bans on gender-affirming care for transgender minors, and the Supreme Court is set to hear arguments in December about Tennessee's ban. We take a closer look at gender-affirming care and the legal arguments that could influence how accessible that care is.Meredithe McNamara, MD, Assistant Professor of Pediatrics, Yale School of MedicineKatie Eyer, JD, Professor of Law, Rutgers Law SchoolJames Blumstein, LLB, University Distinguished Professor of Constitutional Law and Health Law & Policy, Vanderbilt University Law SchoolLearn more and read a full transcript on our website.Want more Tradeoffs? Sign up for our free weekly newsletter featuring the latest health policy research and news.Support this type of journalism today, with a gift.294. How Did Picking a Medicare Plan Get So Hard?
24:36||Season 1, Ep. 294It’s Medicare open enrollment season, and in this episode first aired in 2021, we explain why shopping for a new plan is often tougher than it seems.Guests:Lilyan Grossman, Medicare beneficiaryTricia Neuman, ScD, Senior Vice President and Executive Director of the Program on Medicare Policy, Kaiser Family FoundationAmal Trivedi, MD, Professor of Medicine and Health Services, Policy, and Practice, Brown UniversityLearn more and read a full transcript on our website.Want more Tradeoffs? Sign up for our free weekly newsletter featuring the latest health policy research and news.Support this type of journalism today, with a gift.293. What the Election Could Mean for Obamacare
17:19||Season 1, Ep. 293One of the nation’s leading experts on the Affordable Care Act breaks down its track record and weighs in on the stakes the historic health care law faces in the lead-up to the election.Guest:Larry Levitt, Executive Vice President for Health Policy, KFFLearn more and read a full transcript on our website.Want more Tradeoffs? Sign up for our free weekly newsletter featuring the latest health policy research and news.Support this type of journalism today, with a gift.292. 3 Health Care Decisions Awaiting the Next President
26:27||Season 1, Ep. 292The next U.S. president will have to make consequential choices about the Affordable Care Act, prescription drug prices and abortion. We compare the positions of candidates Kamala Harris and Donald Trump on these major health policy issues. (NOTE: This episode has been updated to clarify the number of people who would lose health coverage if Affordable Care Act enhanced subsidies expired.)Guests:Michael Cannon, Director of Health Policy Studies, Cato InstituteEderlina Co, JD, Associate Professor of Law, University of the PacificCynthia Cox, Vice President and Director of Program on the ACA, KFFStacie Dusetzina, PhD, Professor of Health Policy, Vanderbilt University Medical CenterBenedic Ippolito, PhD, Senior Fellow, American Enterprise InstituteRyan Levi, Reporter/Producer, TradeoffsLearn more and read a full transcript on our website.Want more Tradeoffs? Sign up for our free weekly newsletter featuring the latest health policy research and news.Support this type of journalism today, with a gift.